ClearPoint Neuro (CLPT) Asset Writedowns and Impairment (2013 - 2026)
ClearPoint Neuro (CLPT) posted Asset Writedowns and Impairment of -$95000.0 for Q1 2026, up 51.53% sequentially from -$196000.0 in Q4 2025, and down 143.78% YoY from $217000.0 in Q1 2025.
ClearPoint Neuro (CLPT) Asset Writedowns and Impairment (2013 - 2026) Analysis & Trends
ClearPoint Neuro has reported Asset Writedowns and Impairment for 8 years, with the latest figure at -$95000.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 143.78% year-over-year to -$95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$291000.0 (down 534.33% YoY) and the FY2025 annual result came in at $21000.0, up 107.09% from the prior year.
- Asset Writedowns and Impairment grew to -$95000.0 in Q1 2026 per CLPT's latest filing, from -$196000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $449000.0 in Q3 2023 and troughed at -$361000.0 in Q2 2024.
- A 5-year average of $55071.4 and a median of $13000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment plunged 2133.33% in 2022, then jumped 1520.0% in 2023.
- Over 5 years, Asset Writedowns and Impairment stood at -$25000.0 in 2022, then surged by 1520.0% to $355000.0 in 2023, then plunged by 40.56% to $211000.0 in 2024, then plunged by 192.89% to -$196000.0 in 2025, then soared by 51.53% to -$95000.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$95000.0, -$196000.0, and $217000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | ClearPoint Neuro | 466.38 Mn | 436.98 Mn | 6.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95,000.00 |
| Mar 31, 2026 | -95,000.00 |
| Dec 31, 2025 | -196,000.00 |
| Dec 31, 2025 | -196,000.00 |
| Mar 31, 2025 | 217,000.00 |
| Mar 31, 2025 | 217,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Dec 31, 2024 | 211,000.00 |
| Jun 30, 2024 | -361,000.00 |
| Jun 30, 2024 | -361,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Mar 31, 2024 | -146,000.00 |
| Dec 31, 2023 | 355,000.00 |
| Dec 31, 2023 | 355,000.00 |
| Sep 30, 2023 | 449,000.00 |
| Sep 30, 2023 | 449,000.00 |
| Jun 30, 2023 | 283,000.00 |
| Jun 30, 2023 | 283,000.00 |
| Mar 31, 2023 | 171,000.00 |
| Mar 31, 2023 | 171,000.00 |